DGCI approves vaccine for children 2-18 years age group
2 years ago
The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. The made in India vaccine will be administered in two doses, with a gap of 20 days between the first and second dose. Watch this episode of Non-stop 100.